<DOC>
	<DOCNO>NCT02883595</DOCNO>
	<brief_summary>The purpose study determine whether thymosin alpha 1 effective improve monocyte function desire pharmacologic activity sepsis</brief_summary>
	<brief_title>Efficacy Thymosin Alpha 1 Improving Monocyte Function Sepsis</brief_title>
	<detailed_description>Part 1 : To observe function thymosin alpha 1 sepsis patient via improve phagocytosis , bacteria eradication antigen-presenting monocyte Part 2 : Pharmacokinetics thymosin alpha 1 sepsis</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Thymalfasin</mesh_term>
	<criteria>1 . Written informed consent patient next kin patient unable consent 2 . Age â‰¥18 yrs 3 . Presence sepsis/ septic shock accord sepsis 3.0 1 . Pregnant lactation period . 2 . Age &lt; 18 yr 3 . Receiving immunosuppressive therapy cyclosporine , azathioprine cancer chemotherapy within one month . 4 . History bone marrow , lung , liver , kidney , pancreas small bowel transplantation ; 5 . Acute pancreatitis establish source infection . 6 . Not expect survive 28 day endstage disease . 7 . Participation another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>thymosin alpha 1 ; sepsis ; monocyte ; pharmacokinetics</keyword>
</DOC>